Rhinology Future Debates 2017 by EUFOREA: Novel treatments and surgical solutions in rhinology

Wytske J Fokkens, Benoit Pugin, Claus Bachert, Jean Bousquet, Guy Joos, Renaud Louis, Charles Pilette, Oliver Pfaar, David Price, Emmanuel Prokopakis, Glenis Scadding, Agnieszka Strzembosz, Anders Weilandt, Sven Seys, Peter W Hellings

Research output: Contribution to journalArticle

2 Citations (Scopus)
1 Downloads (Pure)

Abstract

The second Rhinology Future Debates organized by EUFOREA (European Forum for Research and Education in Allergy and Airways diseases) was held in Brussels in December 2017. These debates aim at bringing novel developments in the field of Rhinology to the attention of the medical, paramedical and patient community, in a credible and balanced context. Novel developments are presented by key experts from industry and/or key opinion leaders, and are followed by a lively debate on the potential positioning of new developments in care pathways, the strengths and weaknesses of the novel development(s), and comparisons with existing and/or competing products, devices, and/or molecules. Debate topics presented here include: i) Real World Evidence data in AIT - What does it bring to us?, ii) Nasal turbinate as therapeutic target in patients with turbinate-induced nasal symptoms, and iii) Lessons from biologicals in asthma for ENT physicians. As all debates are recorded and distributed on-line with limited editing (www.rhinology-future.com), EUFOREA aims at maximizing the education on novel developments, allowing a critical appraisal of the future and a more rapid implementation of promising novel tools, techniques and/or molecules in clinical practise. The next Rhinology Future Debate will be in held in 2018. This article is protected by copyright. All rights reserved.

Original languageEnglish
Pages (from-to)1429-1438
Number of pages10
JournalClinical Otolaryngology
Volume43
Issue number6
Early online date31 Jul 2018
DOIs
Publication statusPublished - Dec 2018

Fingerprint

Turbinates
Nose
Education
Industry
Hypersensitivity
Asthma
Physicians
Equipment and Supplies
Therapeutics
Research

Keywords

  • Letter

Cite this

Fokkens, W. J., Pugin, B., Bachert, C., Bousquet, J., Joos, G., Louis, R., ... Hellings, P. W. (2018). Rhinology Future Debates 2017 by EUFOREA: Novel treatments and surgical solutions in rhinology. Clinical Otolaryngology, 43(6), 1429-1438. https://doi.org/10.1111/coa.13184

Rhinology Future Debates 2017 by EUFOREA : Novel treatments and surgical solutions in rhinology. / Fokkens, Wytske J; Pugin, Benoit; Bachert, Claus; Bousquet, Jean; Joos, Guy; Louis, Renaud; Pilette, Charles; Pfaar, Oliver; Price, David; Prokopakis, Emmanuel; Scadding, Glenis; Strzembosz, Agnieszka; Weilandt, Anders; Seys, Sven; Hellings, Peter W.

In: Clinical Otolaryngology, Vol. 43, No. 6, 12.2018, p. 1429-1438.

Research output: Contribution to journalArticle

Fokkens, WJ, Pugin, B, Bachert, C, Bousquet, J, Joos, G, Louis, R, Pilette, C, Pfaar, O, Price, D, Prokopakis, E, Scadding, G, Strzembosz, A, Weilandt, A, Seys, S & Hellings, PW 2018, 'Rhinology Future Debates 2017 by EUFOREA: Novel treatments and surgical solutions in rhinology', Clinical Otolaryngology, vol. 43, no. 6, pp. 1429-1438. https://doi.org/10.1111/coa.13184
Fokkens, Wytske J ; Pugin, Benoit ; Bachert, Claus ; Bousquet, Jean ; Joos, Guy ; Louis, Renaud ; Pilette, Charles ; Pfaar, Oliver ; Price, David ; Prokopakis, Emmanuel ; Scadding, Glenis ; Strzembosz, Agnieszka ; Weilandt, Anders ; Seys, Sven ; Hellings, Peter W. / Rhinology Future Debates 2017 by EUFOREA : Novel treatments and surgical solutions in rhinology. In: Clinical Otolaryngology. 2018 ; Vol. 43, No. 6. pp. 1429-1438.
@article{dd336c12504045eeb7fc636ae584b459,
title = "Rhinology Future Debates 2017 by EUFOREA: Novel treatments and surgical solutions in rhinology",
abstract = "The second Rhinology Future Debates organized by EUFOREA (European Forum for Research and Education in Allergy and Airways diseases) was held in Brussels in December 2017. These debates aim at bringing novel developments in the field of Rhinology to the attention of the medical, paramedical and patient community, in a credible and balanced context. Novel developments are presented by key experts from industry and/or key opinion leaders, and are followed by a lively debate on the potential positioning of new developments in care pathways, the strengths and weaknesses of the novel development(s), and comparisons with existing and/or competing products, devices, and/or molecules. Debate topics presented here include: i) Real World Evidence data in AIT - What does it bring to us?, ii) Nasal turbinate as therapeutic target in patients with turbinate-induced nasal symptoms, and iii) Lessons from biologicals in asthma for ENT physicians. As all debates are recorded and distributed on-line with limited editing (www.rhinology-future.com), EUFOREA aims at maximizing the education on novel developments, allowing a critical appraisal of the future and a more rapid implementation of promising novel tools, techniques and/or molecules in clinical practise. The next Rhinology Future Debate will be in held in 2018. This article is protected by copyright. All rights reserved.",
keywords = "Letter",
author = "Fokkens, {Wytske J} and Benoit Pugin and Claus Bachert and Jean Bousquet and Guy Joos and Renaud Louis and Charles Pilette and Oliver Pfaar and David Price and Emmanuel Prokopakis and Glenis Scadding and Agnieszka Strzembosz and Anders Weilandt and Sven Seys and Hellings, {Peter W}",
note = "This article is protected by copyright. All rights reserved.",
year = "2018",
month = "12",
doi = "10.1111/coa.13184",
language = "English",
volume = "43",
pages = "1429--1438",
journal = "Clinical Otolaryngology",
issn = "1749-4478",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - Rhinology Future Debates 2017 by EUFOREA

T2 - Novel treatments and surgical solutions in rhinology

AU - Fokkens, Wytske J

AU - Pugin, Benoit

AU - Bachert, Claus

AU - Bousquet, Jean

AU - Joos, Guy

AU - Louis, Renaud

AU - Pilette, Charles

AU - Pfaar, Oliver

AU - Price, David

AU - Prokopakis, Emmanuel

AU - Scadding, Glenis

AU - Strzembosz, Agnieszka

AU - Weilandt, Anders

AU - Seys, Sven

AU - Hellings, Peter W

N1 - This article is protected by copyright. All rights reserved.

PY - 2018/12

Y1 - 2018/12

N2 - The second Rhinology Future Debates organized by EUFOREA (European Forum for Research and Education in Allergy and Airways diseases) was held in Brussels in December 2017. These debates aim at bringing novel developments in the field of Rhinology to the attention of the medical, paramedical and patient community, in a credible and balanced context. Novel developments are presented by key experts from industry and/or key opinion leaders, and are followed by a lively debate on the potential positioning of new developments in care pathways, the strengths and weaknesses of the novel development(s), and comparisons with existing and/or competing products, devices, and/or molecules. Debate topics presented here include: i) Real World Evidence data in AIT - What does it bring to us?, ii) Nasal turbinate as therapeutic target in patients with turbinate-induced nasal symptoms, and iii) Lessons from biologicals in asthma for ENT physicians. As all debates are recorded and distributed on-line with limited editing (www.rhinology-future.com), EUFOREA aims at maximizing the education on novel developments, allowing a critical appraisal of the future and a more rapid implementation of promising novel tools, techniques and/or molecules in clinical practise. The next Rhinology Future Debate will be in held in 2018. This article is protected by copyright. All rights reserved.

AB - The second Rhinology Future Debates organized by EUFOREA (European Forum for Research and Education in Allergy and Airways diseases) was held in Brussels in December 2017. These debates aim at bringing novel developments in the field of Rhinology to the attention of the medical, paramedical and patient community, in a credible and balanced context. Novel developments are presented by key experts from industry and/or key opinion leaders, and are followed by a lively debate on the potential positioning of new developments in care pathways, the strengths and weaknesses of the novel development(s), and comparisons with existing and/or competing products, devices, and/or molecules. Debate topics presented here include: i) Real World Evidence data in AIT - What does it bring to us?, ii) Nasal turbinate as therapeutic target in patients with turbinate-induced nasal symptoms, and iii) Lessons from biologicals in asthma for ENT physicians. As all debates are recorded and distributed on-line with limited editing (www.rhinology-future.com), EUFOREA aims at maximizing the education on novel developments, allowing a critical appraisal of the future and a more rapid implementation of promising novel tools, techniques and/or molecules in clinical practise. The next Rhinology Future Debate will be in held in 2018. This article is protected by copyright. All rights reserved.

KW - Letter

U2 - 10.1111/coa.13184

DO - 10.1111/coa.13184

M3 - Article

C2 - 29989349

VL - 43

SP - 1429

EP - 1438

JO - Clinical Otolaryngology

JF - Clinical Otolaryngology

SN - 1749-4478

IS - 6

ER -